Drug Trial Radar · NCT07565103
Safety and Efficacy of SUM-191 for Patients With Bacterial Conjunctivitis
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
426
Planned (sponsor's estimate)
Start
Jun 25, 2026
Primary completion
Aug 15, 2028
Study completion Aug 15, 2028
Sponsor
- Lead sponsor
- Senju USA, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 4, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a seamless Phase I/II, randomized, double-masked, placebo-controlled, multicenter trial to evaluate single and multiple-dose safety and tolerability of SUM-191 in healthy participants in Parts 1 (SAD) and 2 (MAD) ; and multiple-dose efficacy and safety of SUM-191 in participants with bacterial conjunctivitis in Part 3.
Conditions
- Bacterial Conjunctivitis
Interventions
SUM-191Drug
Part 1 (SAD): SUM-191 is administrated a single dose topically. Part 2 (MAD): SUM-191 is administrated TID topically for 6 days. Part 3: SUM-191 is administrated TID topically for 6 days.
PlaceboDrug
Part 1 (SAD): Placebo is administrated a single dose topically. Part 2 (MAD): Placebo is administrated TID topically for 6 days. Part 3: Placebo is administrated TID topically for 6 days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incident of Adverse Events (AEs) (Part 1 and Part 2)Time frame: Part 1: From Day 1 to Day 7 Part 2: From Day 1 to Day 14
- Severity of Adverse Events (AEs) (Part 1 and Part 2)Time frame: Part 1: From Day 1 to Day 7 Part 2: From Day 1 to Day 14
- Clinical cure (Part 3)Time frame: Day 7 or 8
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Segal Drug Trials Inc
Delray Beach, Florida · Recruiting
Austin Clinical Research Unit
Austin, Texas · Completed
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.